GO
Loading...

Enter multiple symbols separated by commas

Video

  • Lightning Round Wednesday, 9 Jan 2013 | 6:40 PM ET
    Lightning Round

    You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

  • Charles River Laboratories CEO on Drug Development Wednesday, 9 Jan 2013 | 6:25 PM ET
    Charles River Laboratories CEO on Drug Development

    Charles River Laboratories CEO James Foster discusses competition in the drug market, drug patents and where his business is headed in 2013.

  • Acorda CEO: Medications More Economical Down the Road Wednesday, 9 Jan 2013 | 6:15 PM ET
    Acorda CEO: Medications More Economical Down the Road

    Acorda Therapeutics CEO Dr. Ron Cohen discusses the phase 2 studies happening on its mobility improvement drug Ampyra, and what's next for the company.

  • Cramer’s Sky-High Idea for Investors Wednesday, 9 Jan 2013 | 6:00 PM ET
    Stocks Edged Higher Today

    Mad Money host Jim Cramer assesses today's business headlines and what it means for the market, including demand in aerospace.

  • Mad Money, Jan. 8, 2013 Tuesday, 8 Jan 2013 | 6:00 PM ET
    Mad Money, Jan. 8, 2013

    Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.

  • Cramer: Yep, Gold Still Belongs in Your Portfolio Tuesday, 8 Jan 2013 | 6:58 PM ET
    No Huddle Offense: Gold Lost Its Luster?

    Mad Money host Jim Cramer shares his view on gold now.

  • Looking for Next Medical Breakthrough? Tuesday, 8 Jan 2013 | 6:45 PM ET
    Looking for Next Medical Breakthrough?

    Biogen Idec CEO George Scangos speaks to Mad Money host about what the company is doing now to treat multiple sclerosis.

  • Lightning Round Tuesday, 8 Jan 2013 | 6:40 PM ET
    Lightning Round

    You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

  • Cramer: Does History Repeat Itself? Tuesday, 8 Jan 2013 | 6:25 PM ET
    Cramer: Does History Repeat Itself?

    Mad Money host Jim Cramer illustrates how past chart patterns could help predict future moves.

  • Regeneron Pharmaceuticals CEO Talks Business Tuesday, 8 Jan 2013 | 6:15 PM ET
    Regeneron Pharmaceuticals CEO Talks Business

    Dr. Leonard Schleifer, president & CEO of Regeneron Pharmaceuticals, offers insight on EYLEA, which is used to treat macular degeneration -- the leading cause of blindness in elderly.

  • Cramer: Insurance Top Theme for 2013 Tuesday, 8 Jan 2013 | 6:10 PM ET
    Cramer: Insurance Top Theme for 2013

    If you're looking for a slow, steady and otherwise boring way in which to invest, Cramer said this year insurance stocks may fill the bill.

  • Cramer: Home Building to Drive Gains in 2013 Tuesday, 8 Jan 2013 | 6:00 PM ET
    Cramer: Home Building to Drive Gains in 2013

    If you're looking for a top theme for 2013, Cramer said check out home building and all the related plays.

  • Mad Money, January 7, 2013 Monday, 7 Jan 2013 | 6:00 PM ET
    Mad Money, January 7, 2013

    Mad Money host and former hedge fund manager, Jim Cramer, provides stock traders with all manner of investing advice.

  • No Huddle Offense: Earnings Season Ahead Monday, 7 Jan 2013 | 6:58 PM ET
    No Huddle Offense: Earnings Season Ahead

    Mad Money host Jim Cramer shares his final thoughts of the day.

  • Exact Sciences CEO: Medicare Spending &  Cologuard Test

    Exact Sciences' CEO Kevin Conroy weighs in on the Medicare spending talks in Washington, and discusses his company's development of non-invasive ways to detect colorectal cancer.

  • Lightning Round Monday, 7 Jan 2013 | 6:40 PM ET
    Lightning Round

    You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

  • Cramer's Top Performers Playoff Monday, 7 Jan 2013 | 6:25 PM ET
    Cramer's Top Performers Playoff

    Mad Money host Jim Cramer begins the annual stock Super Bowl by pitting the best performers in the Dow Jones average against each other.

  • NPS Pharmaceuticals CEO on Gattex's FDA Approval Monday, 7 Jan 2013 | 6:15 PM ET
    NPS Pharmaceuticals CEO on Gattex's FDA Approval

    NPS Pharmaceuticals CEO Dr. Francois Nader discusses the approval of its short bowel syndrome drug Gattex, and what's next for the company.

  • Connecting the Dots of the Market Monday, 7 Jan 2013 | 6:00 PM ET
    Connecting the Dots of the Market

    Mad Money host Jim Cramer explains why it's important to find market themes that will withstand the test of circumstances surrounding the markets. "Themes are the quintessential non-risk on risk off investment that you can fall back on when the market sells off," he says.

  • No Huddle Offense: What to do About Google Friday, 4 Jan 2013 | 6:58 PM ET
    No Huddle Offense: What to do About Google

    Mad Money host Jim Cramer explains why Google's earnings miss was "traumatic."

Contact Video

  • Showtimes

    U.S.
    Monday - Friday 6p ET
    Australia
    Saturday 8a, 1p, 7p SYD
    Sunday 12a, 1a, 8a, 7p SYD
    New Zealand
    Saturday 10a, 3p, 9p NZ
    Sunday 2a, 3a, 10a, 9p NZ

Mad Money Moments

Cramer's New Book